安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Neurizon Therapeutics
Our Phase 1 clinical study has yielded positive results for patients with ALS, highlighting the safety, tolerability and potential for long-term efficacy of NUZ-001 (S-Monepantel) Trial patients have opted to continue treatment by enrolling in a 12-month open-label extension study
- NUZ-001 shows positive early results, headed toward HEALEY trial
NUZ-001 is an oral deworming agent commonly used in veterinary medicine It has an off-target effect of inhibiting mTOR signaling, which is involved in cell growth and the regulation of autophagy, a cellular process by which unneeded or damaged cellular components are broken down
- HEALEY-ALS Platform Trial Undergoes Amendments for ALS . . .
Neurizon Therapeutics announced updates to the HEALEY-ALS trial and promising NUZ-001 results, signaling a major step forward in ALS treatment research
- FDA Lifts Clinical Hold on NUZ-001 - PR Newswire
Neurizon is developing its lead drug candidate, NUZ-001, for the treatment of ALS, which is the most common form of motor neurone disease
- NUZ-001 shows positive results in human 3D brain model
These findings indicate that short-term treatment with NUZ-001 and NUZ-001 Sulfone maintains an excellent safety profile in Tessara’s RealBrain ® micro-tissues
- Neurizons NUZ-001 Decreases TDP-43 Aggregation, a Key Target . . .
Neurizon Therapeutics Limited (ASX: NUZ NUZOA), a biotech company focused on clinical developments for neurodegenerative conditions, is excited to report favorable outcomes from a preclinical evaluation of its primary candidate, NUZ-001
|
|
|